Emedastine

CAS : 87233-61-2

Ref. TM-T3979

Informations sur le produit

• Nom: Emedastine
• Synonymes: LY188695, Emadine, 1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole, 1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-1H-benzimidazole, 1-Methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl)[1,4]diazepane, 1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole, 1H-1,4-Diazepine, 1H-benzimidazole deriv., 1H-benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-, 87233-61-2, Rapimine
• CAS: 87233-61-2

Description

Emedastine (LY188695) is a second generation, selective histamine H1 receptor antagonist with anti-allergic activity. Emedastine reversibly and competitively blocks histamine by binding to H1 receptors, thus blocking its downstream activity. As a result this agent interferes with mediator release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition, emedastine may also inhibit the late-phase allergic reaction mediated through leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva. Emedastine does not affect adrenergic, dopamine, or serotonin receptors.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 302.41
• Formule: C₁₇H₂₆N₄O
• Degré de pureté: 97.1%
• Couleur/Forme: Oil
• InChI: InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3
• Code InChI: InChIKey=KBUZBQVCBVDWKX-UHFFFAOYSA-N
• SMILES: CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21